Antonia is an accomplished scientist, longevity expert, and serial entrepreneur who brings a unique combination of academic excellence and hands-on experience in translating scientific research into practical applications.

Her academic background is in behavioural economics, experimental psychology, and cognitive neuroscience. She pursued her studies across the University of Mannheim (Germany), UC Berkeley (USA), and the University of Oxford (UK). During this period, she was chosen for BCG's Emerald Talent Program, gaining specialised training and insight into senior-level strategy and consulting. Her expertise spans public health interventions, AI, genetics, and behaviour change strategies, as well as developing fMRI applications for use in the U.S. court system.

Antonia's latest academic research focused on canine and comparative genomics of metabolic diseases, such as obesity, at the University of Cambridge.

As former CEO/COO of Gowing Life and Co-Founder/CEO of Oxford Natural, she led research initiatives and the development of scalable applications, including a cure for a chronic autoimmune disease, as well as longevity clinics and technology-enabled treatment programmes, two of which are currently undergoing patent processes. Her previous work also includes pioneering machine learning–based early cancer detection as Co-founder and CSO at Oxford Cancer Analytics (OxCan), where she and her team were recognised with the prestigious University of Oxford's All-Innovate award. Antonia also co-founded the Oxford Biohacking Society. Currently, Antonia is President of the Oxford Society for Ageing and Longevity.